Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

4(36%)

Results Posted

40%(2 trials)

Terminated

1(9%)

Phase Distribution

Ph not_applicable

73%

Ph phase_3

Ph phase_2

18%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 2Efficacy & side effects

2(18.2%)

Phase 3Large-scale testing

1(9.1%)

N/ANon-phased studies

8(72.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(5)

Terminated(1)

Other(1)

Detailed Status

Completed5

Recruiting3

Terminated1

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 3

Trials by Phase

Phase 22 (18.2%)

Phase 31 (9.1%)

N/A8 (72.7%)

Trials by Status

terminated19%

active_not_recruiting19%

unknown19%

recruiting327%

completed545%

Recent Activity

4 active trials

Showing 5 of 11

active_not_recruitingphase_3

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

NCT04539964

recruitingnot_applicable

Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

NCT06773286

completednot_applicable

Clinical Trials (11)

Showing 11 of 11 trials

NCT04539964Phase 3

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Active Not Recruiting

NCT06773286Not Applicable

Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

Recruiting

NCT03372460Not Applicable

tDCS Plus Virtual Reality for PTSD

Completed

NCT05003310Not Applicable

ConsideRAte Study - Splenic Stimulation for RA

Recruiting

NCT04955899Not Applicable

Safety of Splenic Stimulation for RA

Recruiting

NCT05269953Not Applicable

Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder

Completed

NCT03230695Not Applicable

Robotic Therapy and Brain Stimulation in the Early Phase After Stroke

Unknown

NCT03304600Not Applicable

tDCS for Treatment Resistant Obsessive Compulsive Disorder

Completed

NCT03767192Not Applicable

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)

Terminated

NCT02152878Phase 2

Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression

Completed

NCT00977652Phase 2

Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Completed

All 11 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 11